4
Views
31
CrossRef citations to date
0
Altmetric
The chemotherapy of rodent malaria XXXV

Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and ‘P. berghei NS’

&
Pages 459-466 | Received 15 Dec 1982, Published online: 15 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

W. Peters & B. L. Robinson. (1991) The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium. Annals of Tropical Medicine & Parasitology 85:1, pages 5-10.
Read now
L. Donno. (1989) Drug Combinations in the Treatment of Malaria . Journal of Chemotherapy 1:1, pages 52-58.
Read now
L. A. Salako, A. Fadeke Aderounmu, J. O. Laoye, J. Modupe Makinde & R. Aina Adio. (1988) Sensitivity of Plasmodium falciparum to mefloquine—sulphadoxine—pyrimethamine (Fansimef®) in vivo and to mefloquine alone in vitro in Nigeria. Annals of Tropical Medicine & Parasitology 82:4, pages 325-330.
Read now

Articles from other publishers (27)

Manzoor Ahmad Malik, Mohmmad Younus Wani & Athar Adil Hashmi. 2020. Combination Therapy Against Multidrug Resistance. Combination Therapy Against Multidrug Resistance 1 38 .
Waseem A. Wani, Ehtesham Jameel, Umair Baig, Syed Mumtazuddin & Lee Ting Hun. (2015) Ferroquine and its derivatives: New generation of antimalarial agents. European Journal of Medicinal Chemistry 101, pages 534-551.
Crossref
Aric Gregson & Christopher V. Plowe. (2005) Mechanisms of Resistance of Malaria Parasites to Antifolates. Pharmacological Reviews 57:1, pages 117-145.
Crossref
Karen Hayton, Lisa C. Ranford-Cartwright & David Walliker. (2002) Sulfadoxine-Pyrimethamine Resistance in the Rodent Malaria Parasite Plasmodium chabaudi . Antimicrobial Agents and Chemotherapy 46:8, pages 2482-2489.
Crossref
Nicholas White. (1999) Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 354:1384, pages 739-749.
Crossref
W. Peters & B.L. Robinson. 1999. Handbook of Animal Models of Infection. Handbook of Animal Models of Infection 757 773 .
N.J. White. (1998) Preventing antimalarial drug resistance through combinations. Drug Resistance Updates 1:1, pages 3-9.
Crossref
N J White. (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.. Antimicrobial Agents and Chemotherapy 41:7, pages 1413-1422.
Crossref
P.G. Kremsner, A.J.F. Luty & W. Graninger. (1997) Combination chemotherapy for Plasmodium falciparum malaria. Parasitology Today 13:5, pages 167-168.
Crossref
N.J White & P.L Olliaro. (1996) Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria. Parasitology Today 12:10, pages 399-401.
Crossref
Wallace Peters. (1996) Pyronaridine against multiresistant falciparum malaria. The Lancet 347:9001, pages 625.
Crossref
Yngve Bergqvist, Solveig Eckerbom, Helena Larsson & Monireh Malekzadeh. (1991) Reversed-phase liquid chromatographic method for the simultaneous determination of the antimalarial drugs sulfadoxine, pyrimethamine, mefloquine and its major carboxylic metabolite in plasma. Journal of Chromatography B: Biomedical Sciences and Applications 571:1-2, pages 169-177.
Crossref
Wallace Peters. (1990) The prevention of antimalarial drug resistance. Pharmacology & Therapeutics 47:3, pages 499-508.
Crossref
Zuguang Ye, Knox Van Dyke & Vincent Castranova. (1989) The potentiating action of tetrandrine in combination with chloroquine or qinghaosu against chloroquine-sensitive and resistant falciparum malaria. Biochemical and Biophysical Research Communications 165:2, pages 758-765.
Crossref
S.K. Puri & G.P. Dutta. (1989) Delay in emergence of mefloquine resistance in Plasmodium berghei by use of drug combinations. Acta Tropica 46:4, pages 209-212.
Crossref
N.J. White. (1988) The treatment of falciparum malaria. Parasitology Today 4:1, pages 10-14.
Crossref
Winston E. Gutteridge. (1987) New anti-protozoal agents. International Journal for Parasitology 17:1, pages 121-129.
Crossref
J. Karbwang, D. Bunnag, A. M. Breckenridge & D. J. Back. (1987) The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects. European Journal of Clinical Pharmacology 32:2, pages 173-177.
Crossref
D.E. Schwartz, E. Weidekamm, U.B. Ranalder, U.C. Dubach, I. Forgo & B. Weber. (1986) Absence of pharmacokinetic interaction between FansidarR and mefloquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 80:6, pages 1001-1002.
Crossref
C.F. Curtis & L.N. Otoo. (1986) A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 80:6, pages 889-892.
Crossref
Anil K. Saxena & Mridula Saxena. 1986. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques 221 280 .
StephenL. Hoffman, AnthonyJ. Dimpudus, JamesR. Campbell, HarijaniA. Marwoto, Nono Sukri, Diet Rustama, NarainH. Punjabi, H.S. Oetomo, Syahrial Harun, P. Heizmann & LarryW. Laughlin. (1985) RII AND RIII TYPE RESISTANCE OF PLASMODIUM FALCIPARUM TO COMBINATION OF MEFLOQUINE AND SULFADOXINE/PYRIMETHAMINE IN INDONESIA. The Lancet 326:8463, pages 1039-1040.
Crossref
W. Peters. (2009) The problem of drug resistance in malaria. Parasitology 90:4, pages 705-715.
Crossref
T. Harinasuta, R. Lasserre, D. Bunnag, R. Leimer & S. Vinijanont. (1985) TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIA. The Lancet 325:8434, pages 885-888.
Crossref
W. Peters. (1984) New answers through chemotherapy?. Experientia 40:12, pages 1351-1357.
Crossref
Rodney E. Phillips. (1984) Management of Plasmodium falciparum malaria . Medical Journal of Australia 141:8, pages 511-517.
Crossref
Wallace Peters. 1984. Malaria and Babesiosis. Malaria and Babesiosis 141 149 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.